These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
¨
|
REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended December 31, 2011
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Date of event requiring this shell company report………………..
|
|
|
For the transition period from to
|
|
|
Commission File number: 000-23288
|
| ISRAEL |
| (Jurisdiction of incorporation or organization) |
|
None
|
None
|
|
|
Title of each class
|
Name of each exchange on which registered
|
|
|
Ordinary Shares, NIS 0.01 nominal value per share
|
NASDAQ GLOBAL MARKET
|
|
Large accelerated filer
o
|
Accelerated filer
x
|
Non-accelerated filer
o
|
|
US GAAP
x
|
International Financial Reporting Standards as issued
by the International Accounting Standards Board
o
|
Other
o
|
|
PART I.
|
6
|
|
6
|
|
|
6
|
|
|
6
|
|
|
Selected Financial Data
|
6
|
|
Risk Factors
|
8
|
|
20
|
|
|
History and Development of the Company
|
20
|
|
Business Overview
|
22
|
|
Organizational Structure
|
32
|
|
Property, Plant and Equipment
|
32
|
|
33
|
|
|
33
|
|
|
Critical Accounting Policies
|
33
|
|
Recently Enacted Accounting Pronouncements Not Yet Adopted
|
36
|
|
Operating Results
|
37
|
|
Liquidity and Capital Resources
|
41
|
|
Research and development, patents and licenses, etc.
|
42
|
|
Trend Information
|
43
|
|
Off-Balance Sheet Arrangements
|
15
|
|
Tabular disclosure of contractual obligations
|
46
|
|
46
|
|
|
Directors and Senior Management
|
46
|
|
Compensation
|
48
|
|
Board Practices
|
50
|
|
Employees
|
56
|
| Share Ownership |
58
|
|
58
|
|
|
Major Shareholders
|
58
|
|
Related Party Transactions
|
59
|
|
62
|
|
|
63
|
|
|
Markets and Share Price History
|
63
|
|
64
|
|
|
Memorandum and Articles of Association
|
65
|
|
NASD Marketplace Rules and Home Country Practices
|
70
|
|
Material Contracts
|
71
|
|
Exchange Controls
|
71
|
|
Taxation
|
72
|
|
Documents on Display
|
85
|
|
86
|
|
|
Interest Rate Risk
|
86
|
|
Foreign Currency Exchange Risk
|
87
|
|
88
|
|
|
PART II.
|
88
|
|
88
|
|
|
88
|
|
|
88
|
|
|
Disclosure Controls and Procedures
|
89 |
|
Management's Annual Report on Internal Control over Financial Reporting
|
89 |
| Inherent Limitations on Effectiveness of Controls | 89 |
| Changes in Internal Control over Financial Reporting | 90 |
|
90
|
|
90
|
|
|
90
|
|
|
90
|
|
|
91
|
|
|
91
|
|
|
91
|
|
|
91
|
|
|
PART III.
|
93
|
|
93
|
|
|
93
|
|
|
94
|
|
Year Ended December 31
In US$ Thousands
|
||||||||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||
|
Sales
|
$ | 26,784 | $ | 25,554 | $ | 20,526 | $ | 30,399 | $ | 39,633 | ||||||||||
|
Cost of sales
|
16,094 | 15,405 | 12,461 | 17,490 | 22,430 | |||||||||||||||
|
Gross profit
|
10,690 | 10,149 | 8,065 | 12,909 | 17,203 | |||||||||||||||
|
Research and development costs
|
2,208 | 3,048 | 2,716 | 3,280 | 4,165 | |||||||||||||||
|
Sales and marketing expenses
|
1,537 | 2,093 | 1,821 | 2,207 | 2,677 | |||||||||||||||
|
General and administrative expenses
|
1,189 | 1,427 | 1,313 | 1,523 | 1,890 | |||||||||||||||
|
Total operating expenses
|
4,934 | 6,568 | 5,850 | 7,010 | 8,732 | |||||||||||||||
|
Operating income
|
5,756 | 3,581 | 2,215 | 5,899 | 8,471 | |||||||||||||||
|
Financial income, net
|
956 | 1,188 | 909 | 617 | 439 | |||||||||||||||
|
Income before income taxes
|
6,712 | 4,769 | 3,124 | 6,516 | 8,910 | |||||||||||||||
|
Income tax expenses
|
432 | 124 | 305 | 801 | 667 | |||||||||||||||
|
Net income
(1)
|
6,280 | 4,645 | 2,819 | 5,715 | 8,243 | |||||||||||||||
|
Income per share
|
||||||||||||||||||||
|
Basic income per ordinary share
|
$ | 1.03 | $ | 0.69 | $ | 0.42 | $ | 0.84 | $ | 1.20 | ||||||||||
|
Diluted income per ordinary share
|
$ | 1.00 | $ | 0.69 | $ | 0.41 | $ | 0.82 | $ | 1.18 | ||||||||||
|
Weighted average number of ordinary shares used to compute basic income per share (in thousands)
|
6,122 | 6,685 | 6,720 | 6,821 | 6,896 | |||||||||||||||
|
Weighted average number of ordinary shares used to compute diluted income per share (in thousands)
|
6,309 | 6,780 | 6,843 | 6,938 | 6,995 | |||||||||||||||
|
2007
|
2008
|
2009
|
2010
|
2011
|
||||||||||||||||
|
Total assets
|
$ | 45,642 | $ | 51,974 | $ | 55,591 | $ | 63,479 | $ | 72,865 | ||||||||||
|
Total current liabilities
|
$ | 4,712 | $ | 4,735 | $ | 4,399 | $ | 5,827 | $ | 6,438 | ||||||||||
|
Long-term liability
|
$ | 1,596 | $ | 1,905 | $ | 1,967 | $ | 2,222 | $ | 2,153 | ||||||||||
|
Shareholders' equity
|
$ | 39,334 | $ | 45,334 | $ | 49,225 | $ | 55,430 | $ | 64,274 | ||||||||||
|
Capital stock
|
$ | 20 | $ | 20 | $ | 20 | $ | 20 | $ | 20 | ||||||||||
|
Number of ordinary shares issued
(1)
|
6,585,847 | 6,709,034 | 6,824,284 | 6,894,659 | 6,940,059 | |||||||||||||||
|
HIGH
|
LOW
|
|||||||
|
February 2012
|
3.803 | 3.700 | ||||||
|
January 2012
|
3.854 | 3.733 | ||||||
|
December 2011
|
3.821 | 3.727 | ||||||
|
November 2011
|
3.800 | 3.650 | ||||||
|
October 2011
|
3.763 | 3.602 | ||||||
|
September 2011
|
3.725 | 3.574 | ||||||
|
2011
|
3.578 | |||
|
2010
|
3.733 | |||
|
2009
|
3.933 | |||
|
2008
|
3.588 | |||
|
2007
|
4.108 |
|
|
·
|
Substantial research and development and business development expenditures, which could divert funds from other corporate uses and/or have a significant negative effect on our short-term results;
|
|
|
·
|
Diversion of management’s attention from our core business; and
|
|
|
·
|
Entering markets in which we have little or no experience.
|
|
|
·
|
Post-merger integration problems resulting from the combination of any acquired operations with our own operations or from the combination of two or more operations into a new merged entity;
|
|
|
·
|
Diversion of management’s attention from our core business;
|
|
|
·
|
Substantial expenditures, which could divert funds from other corporate uses;
|
|
|
·
|
Entering markets in which we have little or no experience; and
|
|
|
·
|
Loss of key employees of the acquired operations.
|
|
|
·
|
Security appliances
|
|
|
·
|
WAN optimization appliances
|
|
|
·
|
Load balancing and traffic management appliances
|
|
|
·
|
Network-attached storage (NAS)
|
|
|
·
|
Video on Demand servers
|
|
|
·
|
Content Delivery servers
|
|
|
·
|
Internet Service Providers / Web Hosting
|
|
|
·
|
High end computing
|
|
|
·
|
We approach a potential customer or are approached by such customer.
|
|
|
·
|
If the customer shows interest in the products and we believe that achievement of a business relationship with the customer is possible, we ship products for such customer’s evaluation.
|
|
|
·
|
During the evaluation process the customer receives a few of our Server Networking Cards for initial basic testing. If the evaluation process is successful, we ship products for qualification.
|
|
|
·
|
During the qualification process the customer receives a larger amount of our Server Networking Cards for more specific testing, which may include certain customization of our products to its specific needs.
|
|
|
·
|
If the qualification process is successful, we enter into negotiations regarding the terms of a business relationship.
|
|
|
·
|
In some cases, typically with the larger customers, the evaluation and qualification process may take 12 months or more.
|
|
|
·
|
Once all phases mentioned above are concluded, the customer will purchase products from us, in order to incorporate them within its server based systems and sell such systems with our cards embedded in them. The sale of our products within such systems is the objective of our Design Win Model. In most cases once we secure a Design Win our customer will continue to buy our cards for as long as it continues to sell its server based system. Yet, in some cases, we may only be a second source from which a customer purchases, in which case the customer may not necessarily make continuous orders.
|
|
·
|
Inventories - Inventories are stated at the lower of cost or market. Cost is determined using the "average-cost" method. We write down obsolete or slow moving inventory to its market value.
|
|
·
|
Marketable securities – We account for investments which we intend and are able to hold to maturity, that are classified as held-to-maturity investments as defined in ASC 320-10, “Accounting for Certain Investments in Debt and Equity Securities”.
|
|
·
|
Allowance for doubtful accounts - Trade receivables are recorded less the related allowance for doubtful accounts receivable. We consider accounts receivable to be doubtful when it is probable that we will be unable to collect all amounts, taking into account current information and events regarding our customers' ability to repay their obligations. The balance sheet allowance for doubtful debts is determined as a specific amount for those accounts the collection of which is uncertain. We perform our estimates regarding potential doubtful debts based on payment history and correspondence with our customers, and based on new information we receive about the customers’ financial situation. As of December 31, 2011, the allowance for doubtful debts was $20 thousand.
|
|
·
|
Deferred Taxes - We account for income taxes under ASC 740-10 (formally known as SFAS No. 109), "Accounting for Income taxes". Under ASC 740-10, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, and operating loss and tax credit carry forwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred taxes assets to the amount expected to be realized. Valuation allowances in respect of deferred taxes were recorded in respect of the following matters:
|
|
|
§
|
Deferred tax assets that, as we believe, are more likely than not to be realized. In assessing the potential of realization of deferred tax assets, we consider projected future taxable income and tax planning strategies.
|
|
|
§
|
Carry forward tax losses - As of December 31, 2011, our subsidiary had federal carry forward tax losses of approximately $575 thousand to be realized through 2029 and New Jersey state carry forward tax losses of approximately $12 thousand to be realized through 2013. There is no assurance that all of these carry forwards will be realized.
|
|
|
Deferred tax assets and liabilities are classified as current or non-current items in accordance with the nature of the assets or liabilities to which they relate. When there are no underlying assets or liabilities the deferred tax assets and liabilities are classified in accordance with the period of expected reversal. Income tax expenses represent the tax payable for the period and the changes during the period in deferred tax assets and liabilities. As of December 31, 2011, the deferred tax assets were $183 thousand.
|
|
·
|
Accounting for uncertainty in income taxes - Beginning with the adoption of ASC 740 (FASB Interpretation No. 48), “Accounting for Uncertainty in Income Taxes” (FIN 48) as of January 1, 2007, the Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Prior to the adoption of FIN 48, the Company recognized the effect of income tax positions only if such positions were probable of being sustained.
|
|
·
|
Impairment or disposal of long lived assets - We account for long-lived assets in accordance with the provisions of ASC subtopic 360-10 (SFAS No. 144), “Property plant and equipment - overall”. This Statement requires that long-lived assets be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset. Fair value is being determined using discounted cash flow models. Assets to be disposed would be separately presented in the balance sheet and reported at the lower of the carrying amount or fair value less costs to sell.
|
|
·
|
Accounting for Stock-Based Compensation - Effective January 1, 2006, the Company adopted ASC topic 718, “Compensation – stock compensation”. This Statement was adopted using the modified prospective method of application, which requires the Company to recognize compensation cost on a prospective basis. Under this method, the Company recorded stock-based compensation expense for awards granted prior to, but not yet vested as of January 1, 2006, and the Company recognizes compensation expense based on estimated grant date fair value using the Black-Scholes option-pricing model. The share-based awards granted after January 1, 2008, include features that are not supported by the Black and Scholes valuation model, such as expiration date to occur if the closing price of the Shares falling below 50% of grant date Share price, therefore for share-based awards granted after January 1, 2008, the Company recognizes compensation expense based on estimated grant date fair value using the Monte Carlo option-pricing model, or the Binomial option-pricing model.
|
|
2009
|
2010
|
2011
|
||||||||||
|
Sales
|
100 | % | 100 | % | 100 | % | ||||||
|
Cost of sales
|
60.7 | 57.5 | 56.6 | |||||||||
|
Gross profit
|
39.3 | 42.5 | 43.4 | |||||||||
|
Research and development costs
|
13.2 | 10.8 | 10.5 | |||||||||
|
Selling and marketing expenses
|
8.9 | 7.3 | 6.7 | |||||||||
|
General and administrative expenses
|
6.4 | 5.0 | 4.8 | |||||||||
|
Operating Income
|
10.8 | 19.4 | 21.4 | |||||||||
|
Financial income, net
|
4.4 | 2.0 | 1.1 | |||||||||
|
Income before income taxes
|
15.2 | 21.4 | 22.5 | |||||||||
|
Income tax expenses
|
1.5 | 2.6 | 1.7 | |||||||||
|
Net Income
|
13.7 | 18.8 | 20.8 | |||||||||
|
Payments due by period
|
||||||||||||||||||||
|
Contractual Obligations
|
Total
|
Less than 1 year
|
1-3 years
|
3-5 years
|
More than 5 years
|
|||||||||||||||
|
Operating Leases
|
856,000 | 617,000 | 239,000 | |||||||||||||||||
|
Purchase Obligations
|
4,314,000 | 4,314,000 | ||||||||||||||||||
|
Total
|
5,170,000 | 4,931,000 | 239,000 | |||||||||||||||||
|
Name
|
Age
|
Position with Company
|
||
|
Avi Eizenman
|
54
|
Active Chairman of the Board
|
||
|
Shaike Orbach
|
60
|
President, Chief Executive Officer, Director
|
||
|
Zohar Zisapel
|
63
|
Director
|
||
|
Einat Domb-Har
|
44
|
External Director
|
||
|
Ilan Erez
|
44
|
External Director
|
||
|
Eran Gilad
|
44
|
Chief Financial Officer
|
|
|
·
|
goals and objectives relating to the compensation of the Chief Executive Officer and Active Chairman of the Board of Directors, evaluation of their performance in light of such goals and objectives and determination and approval of their compensation based on such evaluation;
|
|
|
·
|
compensation of other directors;
|
|
|
·
|
indemnification and insurance of directors and executive officers;
|
|
|
·
|
employee stock option plans; and
|
|
|
·
|
this committee's performance.
|
|
|
·
|
an employment relationship;
|
|
|
·
|
a business or professional relationship maintained on a regular basis;
|
|
|
·
|
control; and
|
|
|
·
|
service as an office holder.
|
|
|
·
|
the majority includes at least one half of the shares held by non-controlling and disinterested shareholders who are present and voting at the meeting; or
|
|
|
·
|
the total number of shares held by non-controlling and disinterested shareholders that voted against the election of the director does not exceed two percent of the aggregate voting rights in the company.
|
|
|
·
|
The chairman of the board of directors,
|
|
|
·
|
Any director employed by or otherwise providing services to the company or to the controlling shareholder or entity under such controlling shareholder's control,
|
|
|
·
|
Any director who derives his salary primarily from a controlling shareholder,
|
|
|
·
|
A controlling shareholder, or
|
|
|
·
|
Any relative of a controlling shareholder.
|
|
As of December 31
|
2009
|
2010
|
2011
|
|||||||||
|
Total Employees
|
76 | 85 | 96 | |||||||||
|
Marketing, Sales, Customer Services
|
10 | 10 | 12 | |||||||||
|
Research & Development
|
25 | 30 | 31 | |||||||||
|
Manufacturing
|
33 | 37 | 44 | |||||||||
|
Corporate Operations and Administration
|
8 | 8 | 9 | |||||||||
|
Name and Address
|
Number of Shares and Options Owned
1
|
Percent of Outstanding Shares
|
||||||
|
Zohar Zisapel
2
|
1,511,722 | 21.82 | % | |||||
|
Avi Eizenmann
|
235,698 | 3.37 | % | |||||
|
Shaike Orbach
|
* | * | ||||||
|
Einat Domb Har
|
* | * | ||||||
|
Ilan Kalmanovich
|
* | * | ||||||
|
Eran Gilad
|
* | * | ||||||
|
All directors and officers as a group
|
1,753,045 | 25.03 | % | |||||
|
Name of Shareholder
|
Number of Shares and Options Owned
1
|
Percentage of Outstanding Shares
|
Any Significant Change in Past 3 Years
|
||||||
|
Zohar Zisapel
2
|
1,511,722 | 21.82 | % |
no change
|
|||||
|
PERIOD
|
HIGH
|
LOW
|
||||||
|
LAST 6 CALENDAR MONTHS
|
||||||||
|
February 2012
|
17.96 | 16.44 | ||||||
|
January 2012
|
20.33 | 17.30 | ||||||
|
December 2011
|
18.00 | 16.93 | ||||||
|
November 2011
|
18.75 | 15.90 | ||||||
|
October 2011
|
19.33 | 13.11 | ||||||
|
September 2011
|
15.98 | 13.10 | ||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
Fourth Quarter 2011
|
19.33 | 13.11 | ||||||
|
Third Quarter 2011
|
20.75 | 12.17 | ||||||
|
Second Quarter 2011
|
21.91 | 17.00 | ||||||
|
First Quarter 2011
|
21.85 | 16.00 | ||||||
|
Fourth Quarter 2010
|
19.54 | 13.61 | ||||||
|
Third Quarter 2010
|
14.60 | 8.02 | ||||||
|
Second Quarter 2010
|
10.79 | 8.07 | ||||||
|
First Quarter 2010
|
11.49 | 8.50 | ||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2011
|
21.91 | 12.17 | ||||||
|
2010
|
19.54 | 8.02 | ||||||
|
2009
|
10.20 | 4.11 | ||||||
|
2008
|
16.75 | 2.87 | ||||||
|
2007
|
28.24 | 8.40 | ||||||
|
PERIOD
|
HIGH
|
LOW
|
||||||
|
LAST SIX CALENDAR MONTHS
|
||||||||
|
February 2012
|
69.16 | 61.58 | ||||||
|
January 2012
|
73.00 | 65.89 | ||||||
|
December 2011
|
69.00 | 64.66 | ||||||
|
November 2011
|
67.54 | 59.20 | ||||||
|
October 2011
|
68.50 | 50.50 | ||||||
|
September 2011
|
61.69 | 52.26 | ||||||
|
FINANCIAL QUARTERS DURING THE PAST TWO YEARS
|
||||||||
|
Fourth Quarter 2011
|
69.00 | 50.50 | ||||||
|
Third Quarter 2011
|
70.05 | 44.16 | ||||||
|
Second Quarter 2011
|
72.50 | 59.82 | ||||||
|
First Quarter 2011
|
80.64 | 55.25 | ||||||
|
Fourth Quarter 2010
|
71.20 | 50.01 | ||||||
|
Third Quarter 2010
|
54.97 | 30.31 | ||||||
|
Second Quarter 2010
|
40.14 | 31.81 | ||||||
|
First Quarter 2010
|
43.63 | 30.40 | ||||||
|
FIVE MOST RECENT FULL FINANCIAL YEARS
|
||||||||
|
2011
|
80.64 | 44.16 | ||||||
|
2010
|
71.20 | 30.31 | ||||||
|
2009
|
44.44 | 16.20 | ||||||
|
2008
|
59.80 | 13.05 | ||||||
|
2007
|
111.70 | 36.31 | ||||||
|
|
·
|
appointment or termination of our auditors;
|
|
|
·
|
appointment and dismissal of directors;
|
|
|
·
|
approval of interested party acts and transactions requiring general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law;
|
|
|
·
|
a merger as provided in section 320(a) of the Israeli Companies Law;
|
|
|
·
|
the exercise of the powers of the board of directors, if the board of directors is unable to exercise its powers and the exercise of any of its powers is vital for our proper management, as provided in section 52(a) of the Israeli Companies Law.
|
|
|
·
|
all of the directors are permitted to vote on the matter and attend the meeting in which the matter is considered; and
|
|
|
·
|
the matter requires approval of the shareholders at a general meeting.
|
|
|
·
|
A private placement that meets all of the following conditions:
|
|
|
°
|
The private placement will increase the relative holdings of a shareholder that holds five percent or more of the company’s outstanding share capital, assuming the exercise of all of the securities convertible into shares held by that person, or that will cause any person to become, as a result of the issuance, a holder of more than five percent of the company's outstanding share capital.
|
|
|
°
|
20 percent or more of the voting rights in the company prior to such issuance are being offered.
|
|
|
°
|
All or part of the consideration for the offering is not cash or registered securities, or the private placement is not being offered at market terms.
|
|
|
·
|
A private placement which results in anyone becoming a controlling shareholder of the public company.
|
|
|
·
|
any amendment to the articles of association;
|
|
|
·
|
an increase of the company’s authorized share capital;
|
|
|
·
|
a merger; or
|
|
|
·
|
approval of interested party acts and transactions that require general meeting approval as provided in sections 255 and 268 to 275 of the Israeli Companies Law.
|
|
|
·
|
Code of Corporate Conduct.
A code of recommended corporate governance practices has been attached as an annex to the Companies Law. In the explanatory notes to the legislation, the Knesset noted that an "adopt or disclose non-adoption" regulation would be issued by the Israeli Securities Authority with respect to such code. As of the date of this Annual Report, the Israeli Securities Authority has not issued any regulations yet with respect to this code, and it has not been determined to what extent this code will be relevant to Israeli companies that are also listed on non-Israeli stock exchanges.
|
|
|
·
|
Fines.
The Israeli Securities Authority shall be authorized to impose fines on any person or company performing a violation, in connection with a publicly traded company which reports to the Israeli Securities Authority, and specifically designated as a violation under the Amendment.
|
|
|
·
|
Distribution of annual and quarterly reports to shareholders
– Under Israeli law we are not required to distribute annual and quarterly reports directly to shareholders and the generally accepted business practice in Israel is not to distribute such reports to shareholders. We do however make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the Securities and Exchange Commission on Form 6-K.
|
|
|
·
|
Independence, Nomination and Compensation of Directors
–
A majority of our board of directors is not comprised of independent directors as defined in NASDAQ Listing Rule 5605(a)(2). Our board of directors contains two external directors in accordance with the provisions contained in Sections 239-249 of the Israeli Companies Law – 1999. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected for terms of one year or until the following annual meeting, by a general meeting of our shareholders. The nominations for director which are presented to our shareholders are generally made by our directors. Pursuant to the Amendment, one or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of and our board has not adopted a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers is determined in accordance with Israeli law.
|
|
|
·
|
Audit Committee
–
Our audit committee does not meet with all the requirements of NASDAQ Listing Rule 5605. We are of the opinion that the members of our audit committee comply with the requirements of NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933 and all requirements under Israeli law. Our audit committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1).
|
|
|
·
|
Quorum
– Under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our Articles of Association provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required for commencement of business at a general meeting.
|
|
|
·
|
Approval of Related Party Transactions
– All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions, set forth in sections 268 to 275 of the Israeli Companies Law-1999.
|
|
|
·
|
Shareholder Approval
– We seek shareholder approval for all corporate action requiring such approval, in accordance with the requirements of the Israeli Companies Law – 1999.
|
|
Level of Foreign Investment
|
Company Tax Rate
|
Benefit period (years)
|
||||||
|
Over 0% but less than 25%
|
25 | % | 7 | |||||
|
Over 25% but less than 49%
|
25 | % | 10 | |||||
|
49% or more but less than 74%
|
20 | % | 10 | |||||
|
74% or more but less than 90%
|
15 | % | 10 | |||||
|
90% or more
|
10 | % | 10 | |||||
|
|
·
|
Replacement of all future tax incentives under the existing law as amended by the First Amendment; as a result, commencing 2011, industrial companies that meet the conditions set out by the Second Amendment will no longer be entitled to the existing tax incentives provided under the First Amendment, such as the exemption from tax on undistributed profits and a reduced tax rate thereafter but rather to the tax incentives under the Second Amendment.
|
|
|
·
|
Under the transition provisions, any tax benefits obtained prior to 2011 shall continue to apply until expired, unless the company elects to apply the provisions of the Second Amendment to its income.
|
|
|
·
|
The Second Amendment provides that industrial companies meeting the criteria set out by the Investment Law will be eligible for flat tax rates of 10% or 15% for the years 2011 through 2012, 7% or 12.5% for years 2013 through 2014 and 6% or 12% for years 2015 onwards, with the actual tax rates determined by the location of the enterprise. Under the Second Amendment, the tax incentives offered by the Investment Law are no longer dependant neither on minimum qualified investments nor on foreign ownership.
|
|
|
·
|
The Second Amendment allows a company to enjoy both government grants and tax benefits concurrently. Governmental grants will not necessarily be dependent on the extent of enterprise’s investment in assets and/or equipment. Commencing 2011, the approval of “Preferred Enterprise” status by either the Israeli Tax Authorities or the Investment Center will be accepted by the other. Therefore a Preferred Enterprise will be eligible to receive both tax incentives and government grants, under certain conditions.
|
|
2010
|
2011
|
|||||||
|
Audit Fees(1)
|
$ | 95,000 | $ | 105,000 | ||||
|
Audit-Related Fees(2)
|
$ | 5,000 | - | |||||
|
Tax Fees and Other Tax-Related Fees (3)
|
$ | 16,000 | $ | 8,000 | ||||
|
|
·
|
We are not required to distribute annual and quarterly reports directly to shareholders, but we do make our audited financial statements available to our shareholders prior to our annual general meeting and furnish our quarterly and annual financial results with the Securities and Exchange Commission on Form 6-K.
|
|
|
·
|
A majority of our board of directors is not comprised of independent directors as defined in the NASDAQ Listing Rules, but our board of directors contains two external directors in accordance with the Israeli Companies Law – 1999. Israeli law does not require, nor do our external directors conduct, regularly scheduled meetings at which only they are present. In addition, with the exception of our external directors, our directors are elected for terms of one year or until the following annual meeting, by a general meeting of our shareholders. The nominations for director which are presented to our shareholders are also generally made by our directors. Pursuant to the Amendment, one or more shareholders of a company holding at least one percent of the voting power of the company may nominate a currently serving external director for an additional three year term. Israeli law does not require the adoption of and our board has not adopted a formal written charter or board resolution addressing the nomination process and related matters. Compensation of our directors and other officers is determined in accordance with Israeli law.
|
|
|
·
|
Our audit committee has not adopted a formal written audit committee charter specifying the items enumerated in NASDAQ Listing Rule 5605(c)(1). We believe that the members of our audit committee comply with the requirements of the Israeli law, as well as NASDAQ Listing Rule 5605(c)(3) and Rule 10A-3(b) of the general rules and regulations promulgated under the Securities Act of 1933. For a detailed discussion please refer to "Item 6. Directors, Senior Management and Employees- Audit Committee".
|
|
|
·
|
As opposed to NASDAQ Listing Rule 5620(c)(3), which sets forth a minimum quorum for a shareholders meeting, under Israeli law a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our current articles of association provide that a quorum of two or more shareholders, present in person or by proxy, holding shares conferring in the aggregate more than thirty three and a third (33 1/3 %) percent of the voting power of the Company is required.
|
|
|
·
|
All related party transactions are approved in accordance with the requirements and procedures for approval of interested party acts and transactions set forth in the Israeli Companies Law-1999, and are not subject to the review process set forth in NASDAQ Listing Rule 5630. For a detailed discussion please refer to "Item 10. Additional Information- the Israeli Companies Law-1999".
|
|
|
·
|
We seek shareholder approval for all corporate action requiring such approval in accordance with the requirements of the Israeli Companies Law – 1999 rather than under the requirements of the NASDAQ Marketplace Rules, including (but not limited to) the appointment or termination of auditors, appointment and dismissal of directors, approval of interested party acts and transactions requiring general meeting approval as discussed above and a merger.
|
|
1.1
|
Amended and Restated Articles of Association, adopted on January 24, 2008, filed by us as an Exhibit to our registration statement on Form S-8, as filed with the Securities and Exchange Commission on February 11, 2008, and incorporated herein by reference.
|
|
4.1
|
Lease between the Company and Yaakov Metzkin and Dov Segev, for premises in Kfar Sava, Israel, dated November 1, 1994, and amendment dated March 17, 2002, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2001, as filed with the Securities and Exchange Commission on June 27, 2002, and incorporated herein by reference. As this lease and the amendment are written in Hebrew, a summary of each was included in the Exhibit.
|
|
4.2
|
Lease between the Company and Naji Yechezkel Yokenam Industrial Center Ltd. for manufacturing facility in Yokneam, Israel, dated November 20, 2008 filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2008, as filed with the Securities and Exchange Commission on March 23, 2009, and incorporated herein by reference. As this lease is written in Hebrew, a summary was included in the Exhibit.
|
|
4.3
|
Lease between Silicom Connectivity Solutions, Inc. and RAD Data Communications Inc., for space in Mahwah, New Jersey, dated as of September 1, 1997, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2000, as filed with the Securities and Exchange Commission on June 30, 2001, and incorporated herein by reference.
|
|
4.4
|
Sublease Agreement between Silicom Connectivity Solutions, Inc. and Radcom Equipmet, Inc., for space in Paramus, New Jersey, dated as of February 1, 2004, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2003, as filed with the Securities and Exchange Commission on June 30, 2004, and incorporated herein by reference.
|
|
8.
|
List of subsidiaries, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2000, as filed with the Securities and Exchange Commission on June 30, 2001, and incorporated herein by reference.
|
|
11.1
|
Code of Ethics, filed by us as an Exhibit to our annual report on Form 20-F for the fiscal year ended December 31, 2007, as filed with the Securities and Exchange Commission on March 26, 2008, and incorporated herein by reference.
|
|
12.1
|
Certification by Chief Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
|
|
12.2
|
Certification by Chief Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002.
|
|
13.1
|
Certification by Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
13.2
|
Certification by Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
|
15.1
|
Consent of KPMG Somekh Chaikin, Independent Registered Public Accounting Firm.
|
|
SILICOM LIMITED
|
|||
|
By:
|
/s/ Shaike Orbach | ||
|
Shaike Orbach
|
|||
|
Chief Executive Officer
|
|||
|
Page
|
|
|
F - 2
|
|
|
F - 4
|
|
|
F - 6
|
|
|
F - 7
|
|
|
F - 8
|
|
|
F - 9
|
|
2010
|
2011
|
||||||||||
|
Note
|
US$ thousands
|
US$ thousands
|
|||||||||
|
Assets
|
|||||||||||
|
Current assets
|
|||||||||||
|
Cash and cash equivalents
|
3 | 6,657 | 11,483 | ||||||||
|
Short-term bank deposits
|
2E | 9,209 | 5,010 | ||||||||
|
Marketable securities
|
2F, 4 | 8,044 | 9,027 | ||||||||
|
Accounts receivable:
|
|||||||||||
|
Trade, net
|
2G | 6,762 | 8,613 | ||||||||
|
Other
|
5 | 886 | 1,597 | ||||||||
|
Inventories
|
6 | 8,140 | 11,173 | ||||||||
|
Deferred tax assets
|
14H | 50 | 48 | ||||||||
|
Total current assets
|
39,748 | 46,951 | |||||||||
|
Marketable securities
|
4 | 21,560 | 23,667 | ||||||||
|
Assets held for employees’ severance benefits
|
9 | 1,302 | 1,275 | ||||||||
|
Deferred tax assets
|
14H | 219 | 135 | ||||||||
|
Property, plant and equipment, net
|
7 | 650 | 837 | ||||||||
|
Total assets
|
63,479 | 72,865 | |||||||||
|
Avi Eizenman
|
Shaike Orbach
|
Eran Gilad
|
||
|
Chairman of the Board of Directors
|
Chief Executive Officer
|
Chief Financial Officer
|
|
2010
|
2011
|
||||||||||
|
Note
|
US$ thousands
|
US$ thousands
|
|||||||||
|
Liabilities and shareholders’ equity
|
|||||||||||
|
Current liabilities
|
|||||||||||
|
Trade accounts payable
|
3,753 | 3,978 | |||||||||
|
Other accounts payable and accrued expenses
|
8 | 2,074 | 2,460 | ||||||||
|
Total current liabilities
|
5,827 | 6,438 | |||||||||
|
Long-term liability
|
|||||||||||
|
Liability for employees’ severance benefits
|
9 | 2,222 | 2,153 | ||||||||
|
Total liabilities
|
8,049 | 8,591 | |||||||||
|
Commitments and contingencies
|
10 | ||||||||||
|
Shareholders’ equity
|
11 | ||||||||||
|
Ordinary shares, NIS 0.01 par value; 10,000,000 shares
|
|||||||||||
|
authorized; 6,894,659 and 6,940,059 issued as at
|
|||||||||||
|
December 31, 2010 and 2011, respectively;
|
|||||||||||
|
6,879,688 and 6,925,088 outstanding as at
|
|||||||||||
|
December 31, 2010 and 2011, respectively
|
20 | 20 | |||||||||
|
Additional paid-in capital
|
34,644 | 35,245 | |||||||||
|
Treasury shares (at cost) - 14,971 ordinary shares as at
|
|||||||||||
|
December 31, 2010 and 2011
|
(38 | ) | (38 | ) | |||||||
|
Retained earnings
|
20,804 | 29,047 | |||||||||
|
Total shareholders' equity
|
55,430 | 64,274 | |||||||||
|
Total liabilities and shareholders’ equity
|
63,479 | 72,865 | |||||||||
|
2009
|
2010
|
2011
|
||||||||||||||
|
US$ thousands
|
||||||||||||||||
|
Note
|
Except for share and per share data
|
|||||||||||||||
|
Sales
|
12 | 20,526 | 30,399 | 39,633 | ||||||||||||
|
Cost of sales
|
12,461 | 17,490 | 22,430 | |||||||||||||
|
Gross profit
|
8,065 | 12,909 | 17,203 | |||||||||||||
|
Operating expenses
|
||||||||||||||||
|
Research and development
|
2,716 | 3,280 | 4,165 | |||||||||||||
|
Sales and marketing
|
1,821 | 2,207 | 2,677 | |||||||||||||
|
General and administrative
|
1,313 | 1,523 | 1,890 | |||||||||||||
|
Total operating expenses
|
5,850 | 7,010 | 8,732 | |||||||||||||
|
Operating income
|
2,215 | 5,899 | 8,471 | |||||||||||||
|
Financial income, net
|
13 | 909 | 617 | 439 | ||||||||||||
|
Income before income taxes
|
3,124 | 6,516 | 8,910 | |||||||||||||
|
Income taxes
|
14 | 305 | 801 | 667 | ||||||||||||
|
Net income
|
2,819 | 5,715 | 8,243 | |||||||||||||
|
Income per share
:
|
||||||||||||||||
|
Basic income per ordinary share (US$)
|
2S | 0.420 | 0.838 | 1.195 | ||||||||||||
|
Diluted income per ordinary share (US$)
|
0.412 | 0.824 | 1.178 | |||||||||||||
|
Weighted average number of ordinary
|
||||||||||||||||
|
shares used to compute basic income
|
||||||||||||||||
|
per share (in thousands)
|
6,720 | 6,821 | 6,896 | |||||||||||||
|
Weighted average number of ordinary
|
||||||||||||||||
|
shares used to compute diluted income
|
||||||||||||||||
|
per share (in thousands)
|
6,843 | 6,938 | 6,995 | |||||||||||||
|
Additional
|
Total
|
|||||||||||||||||||||||
|
paid-in
|
Treasury
|
Retained
|
shareholders’
|
|||||||||||||||||||||
|
Ordinary shares
|
capital
|
shares
|
earnings
|
Equity
|
||||||||||||||||||||
|
Number
|
||||||||||||||||||||||||
|
of shares
(1)
|
US$ thousands
|
|||||||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
January 1, 2009
|
6,694,063 | 20 | 33,082 | (38 | ) | 12,270 | 45,334 | |||||||||||||||||
|
Exercise of options
|
115,250 | *- | 633 | - | - | 633 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 439 | - | - | 439 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 2,819 | 2,819 | ||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2009
|
6,809,313 | 20 | 34,154 | (38 | ) | 15,089 | 49,225 | |||||||||||||||||
|
Exercise of options
|
70,375 | *- | 259 | - | - | 259 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 231 | - | - | 231 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 5,715 | 5,715 | ||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2010
|
6,879,688 | 20 | 34,644 | (38 | ) | 20,804 | 55,430 | |||||||||||||||||
|
Exercise of options
|
45,400 | *- | 164 | - | - | 164 | ||||||||||||||||||
|
Share-based compensation
|
- | - | 437 | - | - | 437 | ||||||||||||||||||
|
Net income
|
- | - | - | - | 8,243 | 8,243 | ||||||||||||||||||
|
Balance at
|
||||||||||||||||||||||||
|
December 31, 2011
|
6,925,088 | 20 | 35,245 | (38 | ) | 29,047 | 64,274 | |||||||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Cash flows from operating activities
|
||||||||||||
|
Net income
|
2,819 | 5,715 | 8,243 | |||||||||
|
Adjustments required to reconcile net income to
|
||||||||||||
|
net cash provided by operating activities:
|
||||||||||||
|
Depreciation
|
437 | 416 | 379 | |||||||||
|
Write-down of obsolete inventory
|
860 | 780 | 768 | |||||||||
|
Liability for employees’ severance benefits, net
|
23 | 58 | (42 | ) | ||||||||
|
Expense from marketable securities
|
169 | 467 | 462 | |||||||||
|
Share-based compensation expense
|
439 | 231 | 437 | |||||||||
|
Deferred taxes
|
19 | 156 | 86 | |||||||||
|
Capital (gain) loss
|
14 | 2 | (6 | ) | ||||||||
|
Changes in assets and liabilities:
|
||||||||||||
|
Accounts receivable – trade
|
(323 | ) | (1,590 | ) | (1,851 | ) | ||||||
|
Accounts receivable - other
|
(18 | ) | (184 | ) | (717 | ) | ||||||
|
Inventories
|
(268 | ) | (4,243 | ) | (3,801 | ) | ||||||
|
Trade accounts payable
|
(420 | ) | 1,492 | 225 | ||||||||
|
Other accounts payable and accrued expenses
|
53 | 51 | 508 | |||||||||
|
Net cash provided by operating activities
|
3,804 | 3,351 | 4,691 | |||||||||
|
Cash flows from investing activities
|
||||||||||||
|
Proceeds from (investments in) short term bank deposits, net
|
(7,253 | ) | (1,956 | ) | 4,199 | |||||||
|
Purchases of property, plant and equipment
|
(258 | ) | (466 | ) | (486 | ) | ||||||
|
Proceeds from maturity of marketable securities
|
10,300 | 11,303 | 9,531 | |||||||||
|
Purchases of marketable securities
|
(14,572 | ) | (12,972 | ) | (13,071 | ) | ||||||
|
Net cash provided by (used in) investing activities
|
(11,783 | ) | (4,091 | ) | 173 | |||||||
|
Cash flows from financing activities
|
||||||||||||
|
Exercise of options
|
633 | 259 | 164 | |||||||||
|
Net cash provided by financing activities
|
633 | 259 | 164 | |||||||||
|
Effect of exchange rate changes on cash balances held
|
31 | (115 | ) | (202 | ) | |||||||
|
Increase (decrease) in cash and cash equivalents
|
(7,315 | ) | (596 | ) | 4,826 | |||||||
|
Cash and cash equivalents at beginning of year
|
14,568 | 7,253 | 6,657 | |||||||||
|
Cash and cash equivalents at end of year
|
7,253 | 6,657 | 11,483 | |||||||||
|
Supplementary cash flow information
|
||||||||||||
|
A. Non-cash transactions:
|
||||||||||||
|
Investments in fixed assets
|
- | - | 80 | |||||||||
|
B. Cash paid during the year for:
|
||||||||||||
|
Income taxes
|
606 | 1,148 | 623 | |||||||||
|
%
|
||||
|
Machinery and equipment
|
15 - 33 | |||
|
Office furniture and equipment
|
6 - 33 | |||
|
Leasehold improvements
|
10 - 20 | |||
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
Net income attributable to ordinary shares
|
||||||||||||
|
(US$ thousands)
|
2,819 | 5,715 | 8,243 | |||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in basic income per ordinary share calculation
|
6,719,508 | 6,820,721 | 6,896,215 | |||||||||
|
Add assumed exercise of outstanding dilutive potential
|
||||||||||||
|
ordinary shares
|
123,600 | 117,735 | 98,377 | |||||||||
|
Weighted average number of ordinary shares outstanding
|
||||||||||||
|
used in diluted income per ordinary share calculation
|
6,843,108 | 6,938,456 | 6,994,592 | |||||||||
|
Basic income per ordinary shares (US$)
|
0.420 | 0.838 | 1.195 | |||||||||
|
Diluted income per ordinary shares (US$)
|
0.412 | 0.824 | 1.178 | |||||||||
|
Number of options and warrants excluded
|
||||||||||||
|
from the diluted earnings per share calculation
|
||||||||||||
|
because of anti-dilutive effect
|
229,687 | 137,500 | 135,000 | |||||||||
|
|
W.
|
Concentrations of risks
|
|
|
(1)
|
Credit risk
|
|
|
(2)
|
Concentrations of Trade accounts payable
|
|
|
(3)
|
Dominant Single product line
|
|
December 31
|
||||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
||||||||
|
Cash
|
2,566 | 6,461 | ||||||
|
Cash equivalents *
|
4,091 | 5,022 | ||||||
| 6,657 | 11,483 | |||||||
|
|
*
|
Comprised mainly of deposits in banks as at December 31, 2010 and 2011 carrying a weighted average interest of 1.22% and 1.79%, respectively.
|
|
Gross
|
Gross
|
|||||||||||||||
|
unrealized
|
unrealized
|
|||||||||||||||
|
Aggregate
|
holding
|
holding
|
Aggregate
|
|||||||||||||
|
cost basis**
|
gains
|
(losses)
|
fair value*
|
|||||||||||||
|
At December 31, 2011
|
||||||||||||||||
|
Held to maturity:
|
||||||||||||||||
|
Corporate debt securities and
|
||||||||||||||||
|
government debt securities
|
||||||||||||||||
|
Current
|
9,108 | 5 | (100 | ) | 9,013 | |||||||||||
|
Non-Current
|
23,911 | - | (452 | ) | 23,459 | |||||||||||
| 33,019 | 5 | (552 | ) | 32,472 | ||||||||||||
|
At December 31, 2010
|
||||||||||||||||
|
Held to maturity:
|
||||||||||||||||
|
Corporate debt securities and
|
||||||||||||||||
|
government debt securities
|
||||||||||||||||
|
Current
|
8,162 | 18 | (85 | ) | 8,095 | |||||||||||
|
Non-Current
|
21,773 | 74 | (155 | ) | 21,692 | |||||||||||
| 29,935 | 92 | (240 | ) | 29,787 | ||||||||||||
|
December 31, 2011
|
|||||||||||||
|
Net unrealized
|
|||||||||||||
|
Amortized cost
|
holding
gains/(losses)
|
Fair value
|
|||||||||||
|
US$ thousands
|
|||||||||||||
|
Up to 2%
|
25,225 | (415 | ) | 24,810 | |||||||||
|
2.038% - 2.874%
|
7,794 | (132 | ) | 7,662 | |||||||||
| 33,019 | (547 | ) | 32,472 | ||||||||||
|
December 31, 2010
|
|||||||||||||
|
Net unrealized
|
|||||||||||||
|
Amortized cost
|
holding
gains/(losses)
|
Fair value
|
|||||||||||
|
US$ thousands
|
|||||||||||||
|
Up to 4%
|
28,401 | (123 | ) | 28,278 | |||||||||
|
4.063% - 4.241%
|
1,534 | (25 | ) | 1,509 | |||||||||
| 29,935 | (148 | ) | 29,787 | ||||||||||
|
Amortized cost
|
Fair value
|
|||||||
|
US$ thousands
|
||||||||
|
Current maturities
|
9,108 | 9,013 | ||||||
|
Due after one year through 2.75 years
|
23,911 | 23,459 | ||||||
| 33,019 | 32,472 | |||||||
|
Less than 12 months
|
12 months or more
|
Total
|
||||||||||||||||||||||
| Held to maturity |
Unrealized Losses
|
Fair value
|
Unrealized Losses
|
Fair value
|
Unrealized Losses | Fair value | ||||||||||||||||||
|
Corporate debt securities
|
||||||||||||||||||||||||
|
and government debt
|
||||||||||||||||||||||||
|
securities
|
(276 | ) | 17,461 | (276 | ) | 14,005 | (552 | ) | 31,466 | |||||||||||||||
|
December 31
|
||||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
||||||||
|
Accrued interest on marketable securities
|
331 | 325 | ||||||
|
VAT
|
216 | 830 | ||||||
|
Advanced to suppliers
|
17 | 54 | ||||||
|
Income Tax Payable
|
159 | 213 | ||||||
|
Other
|
163 | 175 | ||||||
| 886 | 1,597 | |||||||
|
December 31
|
||||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
||||||||
|
Raw materials and components
|
3,266 | 3,885 | ||||||
|
Products in process
|
3,980 | 5,246 | ||||||
|
Finished products
|
894 | 2,042 | ||||||
| 8,140 | 11,173 | |||||||
|
December 31
|
||||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
||||||||
|
Machinery and equipment
|
2,580 | 2,873 | ||||||
|
Office furniture and equipment
|
275 | 294 | ||||||
|
Leasehold improvements
|
276 | 336 | ||||||
|
Property, plant and equipment
|
3,131 | 3,503 | ||||||
|
Accumulated depreciation
|
(2,481 | ) | (2,666 | ) | ||||
| 650 | 837 | |||||||
|
December 31
|
||||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
||||||||
|
Employees and related liabilities
|
578 | 580 | ||||||
|
Provision for vacation pay
|
587 | 681 | ||||||
|
Employee benefits
|
552 | 766 | ||||||
|
Accrued expenses
|
199 | 266 | ||||||
|
Other
|
158 | 167 | ||||||
| 2,074 | 2,460 | |||||||
|
|
A.
|
Under Israeli law and labor agreements, Silicom is required to make severance payments to retired or dismissed employees and to employees leaving employment in certain other circumstances.
|
|
|
B.
|
According to Section 14 to the Severance Pay Law ("Section 14") the payment of monthly deposits by a company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to the employees that have entered into agreements with the company pursuant to such Section 14. Commencing July 1, 2008, the Company has entered into agreements with a majority of its employees in order to implement Section 14. Therefore, as of that date, the payment of monthly deposits by the Company into recognized severance and pension funds or insurance policies releases it from any additional severance obligation to those employees that have entered into such agreements and therefore the Company incurs no additional liability since that date with respect to such employees. Amounts accumulated in the pension funds or insurance policies pursuant to Section 14 are not supervised or administrated by the Company and therefore neither such amounts nor the corresponding accrual are reflected in the balance sheet.
|
|
|
C.
|
Consequently, the assets held for employees' severance benefits reported on the balance sheet, in respect of deposits for those employees who have signed agreements pursuant to Section 14, represent the redemption value of deposits made through June 30, 2008. The liability for employee severance benefits, with respect to those employees, represents the liability of the Company for employees' severance benefits as of June 30, 2008.
|
|
|
D.
|
Expenses recorded in respect to employees' severance payments for the years ended December 31, 2009, 2010 and 2011 were US$ 252 thousand, US$ 372 thousand and US$ 304 thousand, respectively.
|
|
|
A.
|
Royalty commitments
|
|
|
The premises and facilities occupied by the Company are leased under various operating lease agreements. Furthermore, the Company has entered into several operating lease agreements for motor vehicles in Israel.
|
|
US$ thousands
|
||||
|
Year ended December 31
|
||||
|
2012
|
617 | |||
|
2013
|
157 | |||
|
2014 and on
|
82 | |||
|
|
A.
|
In October 2000, the Board of Directors of Silicom adopted the Silicom Ltd. US Share Option Plan (2000) (the “US Plan”). The US Plan provides that options may be granted to any officer, consultants and certain other present and future employees and directors of Silicom and its subsidiary. Under the terms of the US Plan, up to a maximum of 200,000 ordinary shares of Silicom are reserved for issuance, subject to certain adjustments. The exercise price of the options granted under the US Plan shall be not less than 100 percent (or, in the case of a grant to a holder of more than 10% of Silicom's outstanding shares, 110 percent) of the fair market value of the ordinary shares subject to the option on the date the option is granted. The vesting period of the options is subject to the discretion of the Board. The term of the option shall not exceed 10 years from the date that the option was granted (or five years, in the case of optionees who hold more than 10% of Silicom's outstanding shares).
|
|
|
B.
|
On July 21, 2004, the Board resolved, subject to shareholders’ approval that was given on December 30, 2004, to adopt the Share Option Plan (2004) (the "2004 Plan") and to cancel any authorized share capital of the Company that had been previously reserved and unexercised under the 1993 and 1994 plans, which was not then allocated under such plans or which would become unallocated from time to time as outstanding options expire or are forfeited collectively (the "Cancelled Reserve"). The Cancelled Reserve consisted of 282,750 authorized Ordinary Shares of the Company.
|
|
|
The 2004 Plan, covers up to 582,750 options at a conversion rate of 1:1 to be granted to Israeli employees and directors. Option grants to employees under the 2004 Plan, including terms of vesting and the exercise price are subject to the Board of Directors’ approval. Option grants to directors are subject to the approvals of the Audit Committee, Board of Directors and Shareholders. The term of the options shall not exceed 10 years from the date that the option was granted.
|
|
|
C.
|
No options have been granted by the Company other than to employees and directors, as mentioned above.
|
|
|
D.
|
Options granted to Israeli residents may be granted under Section 102 of the Israeli Income Tax Ordinance pursuant to which the awards of options, or the ordinary shares issued upon their exercise, must be deposited with a trustee for at least two years following the date of grant. Under Section 102, any tax payable by an employee from the grant or exercise of the awards is deferred until the transfer of the awards or ordinary shares by the trustee to the employee or upon the sale of the awards or ordinary shares.
|
|
|
Gains on awards granted under the plan are subjected to capital tax of 25% to be paid by the employee, and the Company is not entitled to a tax deduction.
|
|
|
E.
|
On January 24, 2008, the Company granted, in the aggregate, 200,000 options to certain of its directors and employees under its Share Option Plan (2004) and US Share Option Plan (2000). In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 11.20 and the Option expiration date was the earlier to occur of: (a) January 24, 2016; and (b) the closing price of the Shares falling below US$ 5.60 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Monte Carlo option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
3.36 | % | ||
|
Expected dividend yield
|
0.0 | % | ||
|
Average expected volatility
(b)
|
116.24 | % | ||
|
Termination rate
|
11 | % | ||
|
Suboptimal rate
(c)
|
3.4 |
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
Expenses incurred during the year ended December 31, 2011 in relation to this grant were approximately US$ 7 thousand. As at December 31, 2011, all expenses related to this grant were recognized.
|
|
|
4.
|
All of these options expired by their terms on July 30, 2008 without exercise.
|
|
|
F.
|
On October 15, 2008, the Company granted, in the aggregate, 200,000 options to certain of its directors and employees under its Share Option Plan (2004) and US Share Option Plan (2000). In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 3.82 and the Option expiration date was the earlier to occur of: (a) October 15, 2016; and (b) the closing price of the Shares falling below US$ 1.91 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and the additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Monte Carlo option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
3.73 | % | ||
|
Expected dividend yield
|
0.0 | % | ||
|
Average expected volatility
(b)
|
112.42 | % | ||
|
Termination rate
|
11 | % | ||
|
Suboptimal rate
(c)
|
3.45 |
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
Expenses incurred during the year ended December 31, 2011 in relation to this grant were approximately US$ 33 thousand. As at December 31, 2011, all expenses related to this grant were recognized.
|
|
|
G.
|
On December 21, 2010, the Company granted, in the aggregate, 137,500 options to certain of its directors and employees under its Share Option Plan (2004). In relation to this grant:
|
|
|
1.
|
The exercise price for the options (per ordinary share) was US$ 18.82 and the Option expiration date was the earlier to occur of: (a) December 21, 2018; and (b) the closing price of the Shares falling below US$ 9.41 at any time after the date of grant. 50% of the options vest and become exercisable on the second anniversary of the date of grant and the additional 50% of the options vest and become exercisable on the third anniversary of the date of the grant.
|
|
|
G.
|
(cont’d)
|
|
|
2.
|
The Company recognizes compensation expenses on these options based on estimated grant date fair value using the Binomial
option-pricing model with the following assumptions:
|
|
Average Risk-free interest rate
(a)
|
3.00 | % | ||
|
Expected dividend yield
|
0.0 | % | ||
|
Average expected volatility
(b)
|
82.64 | % | ||
|
Termination rate
|
9 | % | ||
|
Suboptimal rate
(c)
|
3.45 |
|
|
(a)
|
Risk-free interest rate represents risk free US$ zero-coupon US Government Bonds at time of grant.
|
|
|
(b)
|
Expected average volatility represents a weighted average standard deviation rate for the price of the Company’s ordinary shares on the NASDAQ National Market.
|
|
|
(c)
|
Suboptimal rate represents the multiple of the increase in the market share price on the day of grant of the option which, should it come to pass, will lead to exercise of the option by the employee. It is the average suboptimal rate of the Company and similar companies.
|
|
|
3.
|
Expenses incurred during the year ended December 31, 2011 in relation to this grant were approximately US$ 397 thousand. As at December 31, 2011, there was approximately US$ 538 thousand of unrecognized compensation costs related to this grant to be recognized over a weighted average period of 1.46 years.
|
|
|
H.
|
The following table summarizes information regarding stock options as at December 31, 2011:
|
|
Options outstanding
|
Options exercisable
|
||||||||||||||||
|
Weighted
|
Weighted
|
||||||||||||||||
|
average remaining
|
average remaining
|
||||||||||||||||
|
Exercise price
|
Number
|
contractual life
|
Number
|
contractual life
|
|||||||||||||
|
US$
|
of options
|
(in years)
|
of options
|
(in years)
|
|||||||||||||
| 2.53 | 30,000 | 2.99 | 30,000 | 2.99 | |||||||||||||
| 3.82 | 92,425 | 4.79 | 92,425 | 4.79 | |||||||||||||
| 18.82 | 135,000 | 6.97 | - | - | |||||||||||||
| 257,425 | 122,425 | ||||||||||||||||
|
Weighted
|
||||||||||||
|
Weighted
|
average
|
|||||||||||
|
Number
|
average
|
grant date
|
||||||||||
|
of options
|
exercise price
|
fair value
|
||||||||||
|
US$
|
US$
|
|||||||||||
|
Balance at January 1, 2010
|
240,700 | |||||||||||
|
Granted
|
137,500 | 18.82 | 8.69 | |||||||||
|
Exercised
|
(70,375 | ) | 3.68 | 1.81 | ||||||||
|
Forfeited
|
(2,000 | ) | 3.82 | 1.81 | ||||||||
|
Balance at December 31, 2010
|
305,825 | |||||||||||
|
Exercised
|
(45,400 | ) | 3.62 | 1.75 | ||||||||
|
Forfeited
|
(3,000 | ) | 16.32 | 7.54 | ||||||||
|
Balance at December 31, 2011
|
257,425 | |||||||||||
|
Exercisable at December 31, 2011
|
122,425 | |||||||||||
|
|
J.
|
During 2009, 2010 and 2011, the Company recorded share-based compensation expenses. The following summarizes the allocation of the stock-based compensation expenses:
|
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
US$ thousands
|
US$ thousands
|
||||||||||
|
Cost of sales
|
65 | 33 | 24 | |||||||||
|
Research and development costs
|
138 | 71 | 96 | |||||||||
|
Selling and marketing expenses
|
127 | 65 | 134 | |||||||||
|
General and administrative expenses
|
109 | 62 | 183 | |||||||||
| 439 | 231 | 437 | ||||||||||
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
North America
|
14,464 | 22,071 | 29,627 | |||||||||
|
Europe
|
3,507 | 4,174 | 5,174 | |||||||||
|
Rest of the world
|
2,555 | 4,154 | 4,832 | |||||||||
| 20,526 | 30,399 | 39,633 | ||||||||||
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Customer “A”
|
* | 3,440 | 4,882 | |||||||||
|
Customer “B”
|
2,593 | 4,160 | 4,195 | |||||||||
|
Customer “C”
|
2,920 | 3,214 | * | |||||||||
|
|
*
|
Less than 10% of sales.
|
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Interest income
|
1,253 | 1,277 | 1,292 | |||||||||
|
Interest expenses
|
(252 | ) | (416 | ) | (499 | ) | ||||||
|
Exchange rate differences, net
|
72 | (130 | ) | (231 | ) | |||||||
|
Bank charges
|
(164 | ) | (114 | ) | (123 | ) | ||||||
| 909 | 617 | 439 | ||||||||||
|
|
A.
|
Measurement of results for tax purposes under the Israeli Income Tax Regulations (Rules for Maintaining Accounting Records of Foreign Invested Companies and Certain Partnerships and Determining Their Taxable Income) - 1986
|
|
|
B.
|
Israel tax reform
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”)
|
|
|
a.
|
The Company has elected to be taxed under the alternative benefits method, whereby the Company waives grants in return for tax exemptions. For the manufacturing plant in Yokneam the Company is entitled to an exemption from tax on its taxable income for a period of ten years beginning from the year of election
;
For the research and development center the Company is entitled to an exemption from tax on its taxable income for two years beginning from the year of election, and not more than 25%, on its taxable income in the next eight years.
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
|
b.
|
In the event of distribution by the Company of cash dividends out of its retained earnings that were tax exempt due to the “Approved Enterprise” status, the Company would be subject to a 25% corporate tax on the amount distributed, and a further 15% withholding tax would be deducted from the amounts distributed to the shareholders.
|
|
|
c.
|
Should the Company derive income from sources other than the “Approved Enterprise” during the relevant period of benefits, such income will be taxable at the regular corporate tax rates for the applicable year.
|
|
|
2.
|
Accelerated depreciation
|
|
|
3.
|
Conditions for entitlement to the tax benefits
|
|
4.
|
Amendments to the Law
|
|
|
(a)
|
Companies that meet the criteria of the Beneficial Enterprise (Formerly known as Alternative Path of Approved Enterprise) benefits will receive those benefits without prior approval. In addition, there will be no requirement to file reports with the Investment Center. Companies will be required to notify the Israeli Tax Authorities regarding the implementation of the Beneficial Enterprise. Audits will take place via the Israeli Income Tax Authorities as part of the tax audits. Request for pre-ruling is possible.
|
|
|
(b)
|
Tax benefits of the Beneficial Enterprise comparing to regular corporate tax regulations, include lower tax rates or no tax depending on the area and the path chosen, lower tax rates on dividend income and accelerated tax depreciation. The tax benefits do not differ from those prior the amendment.
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
4.
|
Amendments to the Law (cont'd)
|
|
|
(c)
|
In order to receive the tax benefits in the Grant Path or the Beneficial Enterprise, the “Industrial Company” must contribute to the economic independence of Israel’s economy in one of the following ways:
|
|
|
1.
|
Its primary activity is in the Biotechnology or Nanotechnology fields and pre-approval is received from the head of research and development at the Office of the Chief Scientist;
|
|
|
2.
|
Its revenue from a specific country is not greater than 75% of its total revenues that year;
|
|
|
3.
|
25% or more of its revenues are derived from a specific foreign market of at least 12 million residents.
|
|
|
(d)
|
Upon the establishment of a “Beneficial Enterprise”, an investment of at least NIS 300 thousand in production machinery and equipment within three years is required.
|
|
|
(e)
|
For an expansion, a company is required to invest within three years the higher of NIS 300 thousand in production machinery and equipment or a certain percentage of its existing production machinery and equipment.
|
|
|
C.
|
Tax benefits under the Israeli Law for the Encouragement of Capital Investments, 1959 (hereinafter - the “Law”) (cont'd)
|
|
4.
|
Amendments to the Law (cont'd)
|
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Income before income taxes
:
|
||||||||||||
|
Israel
|
3,115 | 6,507 | 8,899 | |||||||||
|
Foreign jurisdiction
|
9 | 9 | 11 | |||||||||
| 3,124 | 6,516 | 8,910 | ||||||||||
|
Current taxes
:
|
||||||||||||
|
Israel
|
358 | 657 | 619 | |||||||||
|
Tax benefits relating to prior years
:
|
||||||||||||
|
Israel
|
(72 | ) | (12 | ) | (38 | ) | ||||||
|
Deferred taxes
:
|
||||||||||||
|
Israel
|
60 | 148 | 73 | |||||||||
|
Foreign jurisdiction
|
(41 | ) | 8 | 13 | ||||||||
| 19 | 156 | 86 | ||||||||||
|
Income tax expense
|
305 | 801 | 667 | |||||||||
|
|
1.
|
A portion of the Company’s income is tax exempt due to the “Approved Enterprise” status granted to its production facilities. Silicom has decided to indefinitely reinvest the amount of the said tax-exempt income, and not to distribute such income as dividends.
|
|
|
2.
|
The tax effects of significant items comprising the Company’s deferred tax assets are as follows:
|
|
December 31
|
December 31
|
|||||||
|
2010
|
2011
|
|||||||
|
US$ thousands
|
US$ thousands
|
|||||||
|
Deferred tax assets:
|
||||||||
|
Accrued employee benefits
|
209 | 148 | ||||||
|
Research and development costs
|
12 | 3 | ||||||
|
Tax loss carryforwards
|
89 | 87 | ||||||
|
Fixed Assets
|
9 | 6 | ||||||
|
Other
|
1 | 2 | ||||||
|
Total gross deferred tax assets
|
320 | 246 | ||||||
|
Less: valuation allowance
|
(51 | ) | (63 | ) | ||||
|
Net deferred tax assets
|
269 | 183 | ||||||
|
In Israel
|
232 | 158 | ||||||
|
Foreign jurisdictions
|
37 | 25 | ||||||
|
Net deferred tax assets
|
269 | 183 | ||||||
|
Current
|
50 | 48 | ||||||
|
Deferred
|
219 | 135 | ||||||
|
Total
|
269 | 183 | ||||||
|
Year ended December 31
|
||||||||||||
|
2009
|
2010
|
2011
|
||||||||||
|
US$ thousands
|
||||||||||||
|
Income before income taxes
|
3,124 | 6,516 | 8,910 | |||||||||
|
Statutory tax rate in Israel
|
26 | % | 25 | % | 24 | % | ||||||
|
Computed expected tax
|
812 | 1,629 | 2,138 | |||||||||
|
Increase (decrease) in taxes resulting from:
|
||||||||||||
|
Non-deductible (deductible) operating expenses
|
126 | 25 | 123 | |||||||||
|
Prior year adjustments
|
(72 | ) | (12 | ) | (38 | ) | ||||||
|
Change in valuation allowance
|
(423 | ) | (17 | ) | 12 | |||||||
|
Tax effect due to “Approved Enterprise” status
|
(66 | ) | (832 | ) | (1,640 | ) | ||||||
|
Changes in tax rate and other
|
(72 | ) | 8 | 72 | ||||||||
|
Income tax expense
|
305 | 801 | 667 | |||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|